- Home
- BDL vs ECOR Comparison
BDL vs ECOR Comparison
Compare BDL & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDL
- ECOR
- Stock Information
- Founded
- BDL 1959
- ECOR 2005
- Country
- BDL United States
- ECOR United States
- Employees
- BDL N/A
- ECOR N/A
- Industry
- BDL Restaurants
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BDL Consumer Discretionary
- ECOR Health Care
- Exchange
- BDL Nasdaq
- ECOR Nasdaq
- Market Cap
- BDL 60.8M
- ECOR 50.1M
- IPO Year
- BDL N/A
- ECOR 2018
- Fundamental
- Price
- BDL $29.05
- ECOR $6.11
- Analyst Decision
- BDL
- ECOR Strong Buy
- Analyst Count
- BDL 0
- ECOR 2
- Target Price
- BDL N/A
- ECOR $25.50
- AVG Volume (30 Days)
- BDL 3.1K
- ECOR 71.2K
- Earning Date
- BDL 08-12-2025
- ECOR 08-06-2025
- Dividend Yield
- BDL 1.72%
- ECOR N/A
- EPS Growth
- BDL 14.76
- ECOR N/A
- EPS
- BDL 2.18
- ECOR N/A
- Revenue
- BDL $198,785,000.00
- ECOR $26,458,000.00
- Revenue This Year
- BDL N/A
- ECOR $23.21
- Revenue Next Year
- BDL N/A
- ECOR $44.10
- P/E Ratio
- BDL $13.31
- ECOR N/A
- Revenue Growth
- BDL 9.31
- ECOR 41.54
- 52 Week Low
- BDL $22.61
- ECOR $4.47
- 52 Week High
- BDL $35.98
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- BDL 45.79
- ECOR 62.63
- Support Level
- BDL $30.11
- ECOR $5.13
- Resistance Level
- BDL $35.18
- ECOR $5.69
- Average True Range (ATR)
- BDL 0.99
- ECOR 0.42
- MACD
- BDL -0.47
- ECOR 0.09
- Stochastic Oscillator
- BDL 0.00
- ECOR 91.27
About BDL Flanigan's Enterprises Inc.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.